Our Management
Access to Medicines - Management
Eisai's policies and programs are supported by full management commitment. We understand that effective management is essential to ensure that policies are implemented correctly, programs help patients in need, and philanthropy achieves its intended impact.
Senior Executive Involvement
At Eisai, the Senior Executive responsible for Public Affairs has overall responsibility for access strategies and reports on these to the Executive Committee, which is chaired by the company President. In addition to ad hoc reporting as required, a report on Eisai's overall approach to Access to Medicines is delivered to the Executive Committee on an annual basis.
Eisai Senior Executive with Access to Medicine responsibility
As of December, 2011, Mr. Yutaka Tsuchiya, Executive Vice President for Corporate Regulatory Compliance, Safety and Quality Assurance, and Public Affairs, has overall responsibility for Eisai's access strategies.
Global Partner Solutions
At Eisai, Global Partner Solutions (GPS) - a division devoted to developing new business models, private-public partnerships, and product development partnerships - leads our access strategies. In partnership with others inside and outside the company, GPS plans and implements Eisai's ATM-related initiatives. With representatives from relevant organization within Eisai, GPS quarterly reviews current strategies and discusses proposed new approaches. As the results of these initiatives, in terms of positive impacts on patients and their families, become available, GPS reviews each initiative and our overall approach. GPS is also responsible for the disclosure of Eisai's ATM initiatives, primarily through the corporate website and corporate publications.
Access to Medicines Advisory Board
Eisai has also established an Access to Medicines Advisory Board comprised of external experts in international policy to provide high-level guidance.
Advisory Board
Access to medicines is a complex problem that cannot be solved by the pharmaceutical industry alone. At Eisai, we recognize that collaborative solutions that allow the private, public and civil sectors to work together are needed to achieve sustainable systems of health care. To make the most effective contribution to improved access to medicines, Eisai needs an advanced understanding of global health and other policy developments.
We have therefore formed an Access to Medicines Advisory Board, comprising several experts in international policy and development, to advise us on our policies and strategies for access to medicines. This Board offers advice and suggestions to Eisai on which efforts are needed, cost-effective, and have significant impact on the development of sustainable solutions for patients and their families. The current members of Eisai's ATM Advisory Board are:
Mr. Shinichi KITAJIMA (Chairman)
Mr. Shinichi Kitajima is the former Japanese Ambassador to the OECD in Paris (2005-2008) and to the international organizations in Geneva (2008-2011). He joined the Japanese Foreign Service in 1971 and served there till 2011, where he was Deputy Vice Minister, Administration (2002-2005).
Mr. Ujal Singh BHATIA
Mr. Ujal Singh Bhatia is the former Ambassador of India to the World Trade Organisation. He joined the Indian Administrative Service in 1974, and served in various capacities in the State Government of Orissa and in New Delhi with the Government of India.
Sir Graham FRY
Sir Graham Fry is the former British Ambassador to Japan. As a member of the British Diplomatic Service from 1972 to 2008, he concentrated mainly on Asian affairs. He spent a total of 12 years in Japan on three postings to Tokyo and was British High Commissioner in Malaysia from 1998 to 2001.
Mr. Ko-Yung TUNG
Mr. Ko-Yung Tung is an international lawyer with Morrison & Foerster, with extensive experience in both the public and private sectors. He has served as Senior Vice President and General Counsel of the World Bank. During his tenure there, he was instrumental in establishing the Global Fund for AIDS, Tuberculosis and Malaria. He is a Visiting Lecturer at Law at Yale Law School where he teaches a course on “Globalization, Development, Poverty and the Law”. He received his undergraduate degree in physics from Harvard University and his law degree from Harvard Law School.
Related Links
